Neumora plans clinical trials, data readouts through 2026

Go back to Neumora plans clinical trials, data readouts through 2026
(NASDAQ: NMRA) Delayed: 1.66 +0.17 (11.41%)
Previous Close $1.49    52 Week High
Open $1.51    52 Week Low
Day High $1.71    P/E N/A 
Day Low $1.50    EPS
Volume 811,304